Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Hoffmann-La Roche |
---|---|
Information provided by: | Hoffmann-La Roche |
ClinicalTrials.gov Identifier: | NCT00468754 |
This trial will compare the metabolic control in type 1 diabetes obtained by continuous infusion of insulin Lispro with that obtained by multiple injections of insulin Lispro and Glargine, a long-acting insulin analogue. Patients will be switched to the alternative treatment after 4 months. Glucose variability in the last month of each treatment will be analyzed.
Condition | Intervention |
---|---|
Diabetes Mellitus, Type 1 |
Device: Insulin pumps |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study |
Official Title: | Comparison Between CSII With Multiple Basal Lispro Infusion Rates and MDI With Lispro and Glargine |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | RD000000275, RD000000275-2007 |
Study First Received: | May 2, 2007 |
Last Updated: | May 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00468754 History of Changes |
Health Authority: | Italy: Ministry of Health |
Metabolic Diseases Autoimmune Diseases Diabetes Mellitus Endocrine System Diseases Insulin LISPRO Diabetes Mellitus Type 1 Insulin |
Hypoglycemic Agents Diabetes Mellitus, Type 1 Glargine Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Hypoglycemic Agents Autoimmune Diseases Metabolic Diseases Immune System Diseases Diabetes Mellitus, Type 1 Physiological Effects of Drugs |
Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Pharmacologic Actions Insulin |